The data convincingly show that the transcription factor Sp1 regulates ephrin-mediated axon guidance in the spinal cord. Although the authors show that Sp1 and its co-activators p300 and CBP are ...

Discover the breakthrough Alzheimer's test that measures tau tangles in blood, simplifying Alzheimer's diagnosis and ...

Sell Axon: The valuation is too high In some ways, Axon stock is a victim of its own success as the valuation has steadily expanded in recent years, putting pressure on the stock. Currently, it ...

Meanwhile, Eli Lilly, AC Immune, Johnson & Johnson, Merck & Co, Anavex and Axon Neurosciences have other anti-tau drugs in early-stage clinical testing. Roche’s head of pharma partnering ...

Founded in Arizona and headquartered in Scottsdale since 1993, building Axon has been my life’s work. As an Arizona resident ...

Axon Enterprise AXON has outperformed the market over the past 5 years by 39.42% on an annualized basis producing an average annual return of 56.57%. Currently, Axon Enterprise has a market ...